English | 繁體

Search in the results

UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Development of a liposomal formulation of acetyltanshinone IIA (ATA) for breast cancer therapy Journal article
Wang, Q, Luo, M, Wei, N, Chang, A, Luo, KQ. Development of a liposomal formulation of acetyltanshinone IIA (ATA) for breast cancer therapy[J]. Molecular Pharmaceutics, 2019, 16(9), 3873-3886.
Authors:  Wang, Q;  Luo, M;  Wei, N;  Chang, A;  Luo, KQ
Favorite |   IF:4.5/4.6 | Submit date：2022/08/26
Anti-breast Cancer Drugs  Acetyltanshinone Iia (Ata)  Mpeg-liposomes  Bioavailability  Pharmacokinetics  Toxicity Study.  
Development of a Liposomal Formulation of Acetyltanshinone IIA for Breast Cancer Therapy Journal article
Wang, Qi, Luo, Man, We, Na, Chang, Alex, Luo, Kathy Qian. Development of a Liposomal Formulation of Acetyltanshinone IIA for Breast Cancer Therapy[J]. Molecular Pharmaceutics, 2019, 16(9), 3873-3886.
Authors:  Wang, Qi;  Luo, Man;  We, Na;  Chang, Alex;  Luo, Kathy Qian
Favorite | TC[WOS]:4 TC[Scopus]:4  IF:4.5/4.6 | Submit date：2020/05/12
Anti-breast Cancer Drugs  Acetyltanshinone Iia (Ata)  Mpeg-liposomes  Bioavailabilit  Pharmacokinetics  Toxicity Study